These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6157042)

  • 21. [Biological markers and germinal tumors of the testis. Value and limitations of the assay of chorionic gonadotrophin hormone and alpha-fetoprotein].
    Bassoulet J; Pabot du Chatelard P; Ricordel I; Auberget JL; Guillemot MC; Merrer J; Timbal Y
    J Urol (Paris); 1988; 94(8):393-6. PubMed ID: 2467947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Determination of specific markers in the blood in tumors of the testis].
    Sakalo VS; Klimenko IA; Iaremko VN; Zaparin VK
    Klin Khir (1962); 1990; (5):47-8. PubMed ID: 1697352
    [No Abstract]   [Full Text] [Related]  

  • 23. [Biological markers for tumours of the testis. Their use in diagnosis, prognosis and follow-up in 200 cases (author's transl)].
    Bellet D; Caillaud JM; Droz JP; Delarue JC; Bohuon C
    Nouv Presse Med; 1981 Nov; 10(40):3293-7. PubMed ID: 6170931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human chorionic gonadotropin (HCG) and alpha-fetoprotein (AFP) in sera and tumor cells of patients with testicular seminoma: a prospective study.
    Javadpour N; McIntire KR; Waldmann TA
    Cancer; 1978 Dec; 42(6):2768-72. PubMed ID: 83187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lectin binding in immunohistologically AFP/HCG positive and negative testicular carcinoma].
    Henke H; Balducci M; Dunzendorfer U
    Urol Int; 1987; 42(1):53-7. PubMed ID: 2438837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum and cellular biologic tumor markers in patients with urologic cancer.
    Javadpour N
    Hum Pathol; 1979 Sep; 10(5):557-68. PubMed ID: 93569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experience with serum alpha-fetoprotein and human chorionic gonadotropin in non-seminomatous testicular tumors.
    Fowler JE; Taylor G; Blom J; Stutzman RE
    J Urol; 1980 Sep; 124(3):365-8. PubMed ID: 6159485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tumor markers in malignant tumors].
    Ogreid P
    Tidsskr Nor Laegeforen; 1980 Apr; 100(12):678-9. PubMed ID: 6158119
    [No Abstract]   [Full Text] [Related]  

  • 29. Tumour markers in testicular cancer.
    Light PA
    J R Soc Med; 1985; 78 Suppl 6(Suppl 6):19-24. PubMed ID: 2582118
    [No Abstract]   [Full Text] [Related]  

  • 30. Serum alpha-fetoprotein and human chorionic gonadotropin as markers for the effect of postoperative radiation therapy and/or chemotherapy in testicular cancer.
    Schultz H; Sell A; Nørgaard-Pedersen B; Arends J
    Cancer; 1978 Nov; 42(5):2182-6. PubMed ID: 82474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
    Lange PH; McIntire KR; Waldmann TA; Hakala TR; Fraley EE
    J Urol; 1977 Oct; 118(4):593-6. PubMed ID: 72163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical use of alpha fetoproteins (AFP) and choriogenic gonadotropins (CGT) in terminal testicular tumors].
    Vopr Onkol; 1979; 25(9):111-2. PubMed ID: 90428
    [No Abstract]   [Full Text] [Related]  

  • 33. The value of serial measurement of both human chorionic gonadotropin and alpha-fetoprotein for monitoring germinal cell tumors.
    Perlin E; Engeler JE; Edson M; Karp D; McIntire KR; Waldmann TA
    Cancer; 1976 Jan; 37(1):215-9. PubMed ID: 55299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pregnancy-specific beta 1-glycoprotein: a tumor marker].
    Horne CH; Bremner RD
    Ric Clin Lab; 1984; 14 Suppl 2():33-8. PubMed ID: 6085182
    [No Abstract]   [Full Text] [Related]  

  • 35. [Assay of chorionic gonadotrophin, follicle-stimulating hormone and alpha-fetoprotein in the efferent blood in germinal tumors of the testis].
    Henry R; Wiriot G; Longeon A; Timbal Y; Degrelle H
    Presse Med; 1986 Jun; 15(26):1223-6. PubMed ID: 2428029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of testicular carcinoma on ipsilateral spermatogenesis.
    Ho GT; Gardner H; DeWolf WC; Loughlin KR; Morgentaler A
    J Urol; 1992 Sep; 148(3):821-5. PubMed ID: 1380990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spermatic cord beta-human chorionic gonadotropin levels in seminoma and their clinical implications.
    Mumperow E; Hartmann M
    J Urol; 1992 Apr; 147(4):1041-3. PubMed ID: 1372658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testicular cancer: role of biological tumor markers.
    Pearson JC; Spaulding JT; Friedman MA
    Cancer Treat Rev; 1979 Dec; 6(4):217-21. PubMed ID: 93978
    [No Abstract]   [Full Text] [Related]  

  • 39. Quantification of alpha-fetoprotein and beta-HCG in testis tumor patients.
    Dunzendorfer U; Jurincic C
    Urol Int; 1987; 42(4):248-53. PubMed ID: 2445089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current concepts in management of testicular tumor.
    Javadpour N
    Urol Surv; 1978 Jun; 28(3):89-94. PubMed ID: 80873
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.